O-GlcNAc modification of nucleocytoplasmic proteins and diabetes (original) (raw)

Abstract

Nuclear and cytosolic proteins are glycosylated on serine or threonine residues by _O_-linked β-_N_-acetylglucosamine (_O_-GlcNAc). _O_-GlcNAc modification is one of various posttranslational modifications and seems to be involved in the modulation of transcription and signal transduction. Accumulating data suggest a role for _O_-GlcNAc-modified proteins in diabetes, acting as a glucose sensor. It has been suggested that the hexosamine biosynthetic pathway is involved in the mechanism causing insulin resistance and diabetic complications. Excess glucose entering into the hexosamine biosynthetic pathway might cause elevated _O_-GlcNAc modification of various proteins. In this article, we review the current data regarding the relationship between _O_-GlcNAc modification and diabetes.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan
    Yoshihiro Akimoto, Hiroshi Hirano & Hayato Kawakami
  2. Department of Biological Chemistry, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Gerald W. Hart
  3. Nittai Jusei Medical College for Judo Therapeutics, Tokyo, Japan
    Hiroshi Hirano

Authors

  1. Yoshihiro Akimoto
    You can also search for this author inPubMed Google Scholar
  2. Gerald W. Hart
    You can also search for this author inPubMed Google Scholar
  3. Hiroshi Hirano
    You can also search for this author inPubMed Google Scholar
  4. Hayato Kawakami
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toYoshihiro Akimoto.

Rights and permissions

About this article

Cite this article

Akimoto, Y., Hart, G., Hirano, H. et al. _O_-GlcNAc modification of nucleocytoplasmic proteins and diabetes.Med Mol Morphol 38, 84–91 (2005). https://doi.org/10.1007/s00795-004-0264-1

Download citation

Key words